Skip to main content
. 2017 Oct 26;12(10):e0187086. doi: 10.1371/journal.pone.0187086

Fig 4. Lymph node weight and proliferation.

Fig 4

A) Lymph node (LN) weight at different time points after injection of vehicle, AT1-, or MLL tumor cells into the prostate compared to LNs from treatment-naïve animals (bars represent mean +/- SD, n = 7–8 animals/group, * p < 0.05). B) Representative sections in two different magnifications showing proliferation (Ki67, brown) in vehicle-, AT1-, and MLL-LNs at day 10 compared to treatment-naïve LNs (insert shows control staining without primary antibody).